Search

everythinglearnresearchcommunity

for

Search:↓

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Wharton's jelly secretomes are best for promoting blood vessel growth.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Prolactin may be important for skin growth and immune function.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some cancer treatments can cause permanent hair loss.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Stem cells from umbilical cord blood may prevent hair loss caused by certain medications.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.